Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device. [electronic resource]
- BMJ (Clinical research ed.) Dec 2015
- h6431 p. digital
Publication Type: News
1756-1833
10.1136/bmj.h6431 doi
Atrial Fibrillation--blood Equipment Failure Factor Xa Inhibitors--therapeutic use Humans International Normalized Ratio--instrumentation Rivaroxaban--therapeutic use Stroke--blood